Skip to main content

Jon Ander Aguirre Carrillo

Jon Ander Aguirre Carrillo

Jon Ander Aguirre Carrillo

Jon Ander Aguirre Carrillo

Related news

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.

Related professionals

Gade Seck

Gade Seck

Maintenance staff and general services
Infectious Diseases
Read more
Anna Server Salvà

Anna Server Salvà

Main researcher
Musculoskeletal Tissue Engineering
Read more
Rubén Martínez Jaen

Rubén Martínez Jaen

Tècnic de Recerca - Grau Mig
Clinical Trials Management
Clinical Research Development Area
Read more
Berta Ferrer Fábrega

Berta Ferrer Fábrega

Biomedical Research in Melanoma
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.